nva237
Showing 1 - 21 of 21
Renal Impairment Trial in Moscow (NVA237)
Completed
- Renal Impairment
- NVA237
-
Moscow, Russian FederationNovartis Investigative Site
Dec 16, 2020
COPD Trial in Worldwide (NVA237, Placebo, Salbutamol)
Completed
- Chronic Obstructive Pulmonary Disease
- NVA237
- +2 more
-
Genk, Limburg, Belgium
- +80 more
Jun 21, 2019
COPD Trial (NVA237, Placebo to NVA237)
Withdrawn
- Chronic Obstructive Pulmonary Disease
- NVA237
- Placebo to NVA237
- (no location specified)
Apr 19, 2017
COPD Trial in Spartanburg, Albrechtstrasse 14 (Placebo, NVA237)
Completed
- Chronic Obstructive Pulmonary Disease
- Placebo
- NVA237
-
Spartanburg, South Carolina
- +1 more
Aug 2, 2016
Pulmonary Disease, Chronic Obstructive Trial (NVA237, Tiotropium Respimat®)
Withdrawn
- Pulmonary Disease, Chronic Obstructive
- NVA237
- Tiotropium Respimat®
- (no location specified)
Aug 19, 2016
COPD: COPD Trial in Switzerland (QAB149, Placebo, NVA237)
Completed
- Chronic Obstructive Pulmonary Disease: COPD
- QAB149
- +2 more
-
Faltigberg-Wald, ZH, Switzerland
- +10 more
Jan 11, 2016
COPD (COPD) Trial in United States (NVA237, Long-acting beta 2-agonist (LABA), Placebo)
Completed
- Chronic Obstructive Pulmonary Disease (COPD)
- NVA237
- +2 more
-
Gulf Shores, Alabama
- +60 more
Feb 17, 2016
Asthma Trial (NVA237, Placebo to NVA237, salbutamol/ albuterol)
Withdrawn
- Asthma
- NVA237
- +2 more
- (no location specified)
Apr 10, 2015
COPD (COPD) Trial in Worldwide (QVA149, QAB149, NVA237)
Completed
- Chronic Obstructive Pulmonary Disease (COPD)
- QVA149
- +3 more
-
Birmingham, Alabama
- +142 more
Mar 2, 2016
COPD Trial in Germany (NVA237, Tiotropium, Placebo to NVA237)
Completed
- Chronic Obstructive Pulmonary Disease
- NVA237
- +4 more
-
Berlin, Germany
- +13 more
Dec 19, 2014
COPD Trial in United States (NVA237, Placebo)
Completed
- Chronic Obstructive Pulmonary Disease
- NVA237
- Placebo
-
Homewood, Alabama
- +53 more
Feb 12, 2015
COPD Trial in United States (NVA237, Placebo)
Completed
- Chronic Obstructive Pulmonary Disease
- NVA237
- Placebo
-
*See Various Dept.'s*, Arizona
- +58 more
Mar 9, 2015
COPD (COPD) Trial in Worldwide (NVA237, Placebo)
Completed
- Chronic Obstructive Pulmonary Disease (COPD)
- NVA237
- Placebo
-
Beijing, Beijing, China
- +31 more
Jul 16, 2014
COPD (COPD) Trial in Worldwide (QVA149, QAB149, NVA237)
Completed
- Chronic Obstructive Pulmonary Disease (COPD)
- QVA149
- +3 more
-
Huntsville, Alabama
- +94 more
Jul 13, 2015
COPD Trial in Worldwide (NVA237, Tiotropium, Placebo to tiotropium)
Completed
- Chronic Obstructive Pulmonary Disease
- NVA237
- +4 more
-
Toronto, Ontario, Canada
- +75 more
Apr 22, 2014
COPD Trial in Worldwide (QVA149, NVA237, QAB149)
Completed
- Chronic Obstructive Pulmonary Disease
- QVA149
- +3 more
-
Feldbach, Austria
- +25 more
Jan 16, 2014
COPD Trial in Worldwide (QVA149, NVA237, tiotropium)
Completed
- Chronic Obstructive Pulmonary Disease
- QVA149
- +3 more
-
Birmingham, Alabama
- +344 more
Oct 29, 2013
COPD Trial in Japan (NVA237, Tiotropium)
Completed
- Chronic Obstructive Pulmonary Disease
- NVA237
- Tiotropium
-
Iizuka, Fukuoka, Japan
- +39 more
Dec 12, 2012
COPD Trial in Vilvoorde, Rueil-Malmaison,, Tokyo (NVA237, Placebo, Tiotropium)
Completed
- Chronic Obstructive Pulmonary Disease
- NVA237
- +2 more
-
Vilvoorde, Belgium
- +2 more
May 3, 2012
COPD Trial in Worldwide (NVA237, Placebo)
Completed
- Chronic Obstructive Pulmonary Disease
- NVA237
- Placebo
-
Spartanburg, South Carolina
- +9 more
Apr 10, 2012
COPD (COPD) Trial in Denmark, Germany (NVA237, Placebo)
Completed
- Chronic Obstructive Pulmonary Disease (COPD)
- NVA237
- Placebo
-
Copenhagen, Denmark
- +3 more
Dec 27, 2007